Category : Search result: pharmaceutical sales


FDA approves groundbreaking Alzheimer's drug

The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment, sparking debate over its efficacy and high cost while offering hope to millions.

Why Muscle Cars Are Beating EVs in US Sales

Despite the push for electric vehicles, American drivers are clinging to their petrol-powered muscle cars, with sales soaring as EVs struggle to win over consumers.

Top Champagne Deals 2024: Save on Bubbly

Discover the finest champagne deals of 2024, featuring top brands at unbeatable prices. Whether for celebrations or gifts, find the perfect bubbly without breaking the bank.

Trump's pharma tariffs could hit UK drug prices

Former US President Donald Trump has floated the idea of imposing tariffs on imported pharmaceuticals, a move that could significantly impact the UK's healthcare sector and drug prices.

UK car sales surge 14% in February

New car registrations in the UK rose by 14% in February, marking the best performance since the pandemic. Electric vehicle demand slows, while hybrids gain traction.

Diageo shares plunge on profit warning

Diageo's stock takes a hit after issuing a profit warning, dragging the FTSE 100 down. Analysts weigh in on the beverage giant's challenges in Latin America and beyond.

Walmart cuts Lego prices by up to 40%

Walmart shoppers can now enjoy massive discounts on Lego sets, making it the perfect time to grab these iconic childhood toys at unbeatable prices.

US home sales crash to 13-year low

Home sales in the US have plummeted to their lowest level in 13 years, sparking fears of a worsening housing crisis. Experts reveal what this means for buyers and sellers.

Starmer's bold plan to cut UK drug prices

Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?

Trump tariffs may hike Aussie medicine prices

New US tariffs could drastically increase the cost of essential medicines in Australia, putting the Pharmaceutical Benefits Scheme at risk. Experts warn of dire consequences for patients.

Page 1 of 3